Wall Street is looked a little more green Wednesday, as bioplastics company Danimer Scientific began trading on the New York Stock Exchange. Danimer Scientific has chosen to go public via the increasingly popular SPAC route, merging with blank-check company Live Oak. Stephen Croskrey, CEO at Danimer Scientific, explains how conditions brought on by the coronavirus pandemic led his company to choose the SPAC route as a means to go public more quickly.